Price $4.55 |
Market Cap
46.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
6.0
|
P/B
1.22
|
P/S
0.85
|
Dividend %
-
|
|
P/CF
6.0
|
P/FCF
6.9
|
Op. Cash Flow
11.2K
|
FCF
0.6
|
|
Op. Margin
13.00%
|
Net Margin
14.70%
|
ROE
22.60%
|
ROI
12.30%
|
|
ROA
15.20%
|
EPS Growth
286.20%
|
Current Ratio
2.3
|
Debt/Equity
5.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biostar Pharmaceuticals Inc (BSPM) | $1.80 | - | - | 3.5M | Strong Buy |
| Aviragen Therapeutics Inc (AVIR) | $0.72 | - | - | 25.1M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.69 | - | - | 4.5M | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.88 | - | - | 14.3M | Strong Buy |
| DURECT Corporation (DRRX) | $1.94 | - | - | 258.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
